Detection of Inducible Clindamycin Resistance (MLSBi) among Methicillin-resistant Staphylococcus aureus (MRSA) from Libya Mohamed Omar Ahmed 1, Mohamed Alghazali 2, S G Amri 3, Abdelalbaset Abuzweda 4 1 - Department of Microbiology, Biotechnology Research Center, Tripoli, Libya P.O. Box 30313 Department of Veterinary Microbiology, Faculty of Veterinary Medicine, Al-Fateh University P.O. Box 13662, Tripoli, Libya 2 - Biotechnology Research Center, Department of Microbiology, P.O. Box 30313,Tripoli, Libya, Tel.no:00218925271773 3 - Burns and Plastic Surgery Centre, Tripoli, Libya 4 - Biotechnology Research Center, Department of Microbiology, P.O. Box, 30313, Tripoli, Libya, Tel.no:00218925164865
Libyan J Med 2010; 5 0-0 aaICID: 900478
Article type: Original article
IC™ Value: 3.00
Abstract provided by Publisher
Methicillin-resistant Staphylococcus Aureus (MRSA) first emerged as nosocomial pathogens in the early 1960’s are of great concern to public health and highly reported in human clinical samples. There are major international concerns about rising levels of MRSA and multi-drug resistant S. aureus owing to the difficulties of treating infections and the ease with which MRSA spreads within hospitals. Until recently, most infections of MRSA were acquired primarily in hospital settings, but now MRSA is responsible for both hospital and community acquired infections. The objective of this study was to investigate MRSA collected isolates for MLSB phenotypes in particular inducible clindamycin resistance (MLSBi).